Cefpodoxime Proxetil

Cefpodoxime Proxetil

4.0 Moderate risk

Cefpodoxime Proxetil & Bladder transitional cell carcinoma

100.0%

of users reported Bladder transitional cell carcinoma

58.6%

also reported Hospitalization

100.0%

are women

Most common medical consequences

Hospitalization
58.6%
Severe reaction
41.4%

Have you experienced any negative side effects from this medication?

Cefpodoxime Proxetil: general information

Most common side effects (1)

Most commonly affected ages

60 - 69 years
100.0%